摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl (2S,3S,4'R,4a'S,7a'R,12b'S)-3'-(cyclopropylmethyl)-4a'-hydroxy-9'-methoxy-2',3',4',4a',5',6'-hexahydro-1'H,7a'H-spiro[oxirane-2,7'-[4,12]methanobenzofuro[3,2-e]isoquinoline]-3-carboxylate | 1186028-94-3

中文名称
——
中文别名
——
英文名称
ethyl (2S,3S,4'R,4a'S,7a'R,12b'S)-3'-(cyclopropylmethyl)-4a'-hydroxy-9'-methoxy-2',3',4',4a',5',6'-hexahydro-1'H,7a'H-spiro[oxirane-2,7'-[4,12]methanobenzofuro[3,2-e]isoquinoline]-3-carboxylate
英文别名
——
ethyl (2S,3S,4'R,4a'S,7a'R,12b'S)-3'-(cyclopropylmethyl)-4a'-hydroxy-9'-methoxy-2',3',4',4a',5',6'-hexahydro-1'H,7a'H-spiro[oxirane-2,7'-[4,12]methanobenzofuro[3,2-e]isoquinoline]-3-carboxylate化学式
CAS
1186028-94-3
化学式
C25H31NO6
mdl
——
分子量
441.524
InChiKey
KUAPTDJZMCLPBZ-QWCHHGFRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.96
  • 重原子数:
    32.0
  • 可旋转键数:
    5.0
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.72
  • 拓扑面积:
    80.76
  • 氢给体数:
    1.0
  • 氢受体数:
    7.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    ethyl (2S,3S,4'R,4a'S,7a'R,12b'S)-3'-(cyclopropylmethyl)-4a'-hydroxy-9'-methoxy-2',3',4',4a',5',6'-hexahydro-1'H,7a'H-spiro[oxirane-2,7'-[4,12]methanobenzofuro[3,2-e]isoquinoline]-3-carboxylate苯胺正丁基锂 作用下, 以 四氢呋喃 为溶剂, 以80%的产率得到(4R,4aS,7S,7aR,12bS,14R)-3-(cyclopropylmethyl)-7-hydroxy-9-methoxy-N-phenyl-1,2,3,4,5,6,7,7a-octahydro-4a,7-(epoxymethano)-4,12-methanobenzofuro[3,2-e]isoquinoline-14-carboxamide
    参考文献:
    名称:
    Drug design and synthesis of a novel κ opioid receptor agonist with an oxabicyclo[2.2.2]octane skeleton and its pharmacology
    摘要:
    A conformational analysis of kappa opioid receptor agonists, TRK-820 and U-50,488H indicated an active conformation of TRK-820 in which the C-ring was in the boat form with the 14-OH interacting with the amide nitrogen. Based on the obtained active conformation of TRK-820, we designed and synthesized a novel kappa agonist KNT-63 with oxabicyclo[2.2.2]octane skeleton. KNT-63 showed profound antinociceptive effects via the kappa receptor which were as potent as that of TRK-820. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.11.027
  • 作为产物:
    描述:
    纳曲酮EP杂质J氯乙酸乙酯 在 sodium hydride 作用下, 以 四氢呋喃 为溶剂, 以48%的产率得到ethyl (2S,3R,4'R,4a'S,7a'R,12b'S)-3'-(cyclopropylmethyl)-4a'-hydroxy-9'-methoxy-2',3',4',4a',5',6'-hexahydro-1'H,7a'H-spiro[oxirane-2,7'-[4,12]methanobenzofuro[3,2-e]isoquinoline]-3-carboxylate
    参考文献:
    名称:
    Drug design and synthesis of a novel κ opioid receptor agonist with an oxabicyclo[2.2.2]octane skeleton and its pharmacology
    摘要:
    A conformational analysis of kappa opioid receptor agonists, TRK-820 and U-50,488H indicated an active conformation of TRK-820 in which the C-ring was in the boat form with the 14-OH interacting with the amide nitrogen. Based on the obtained active conformation of TRK-820, we designed and synthesized a novel kappa agonist KNT-63 with oxabicyclo[2.2.2]octane skeleton. KNT-63 showed profound antinociceptive effects via the kappa receptor which were as potent as that of TRK-820. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.11.027
点击查看最新优质反应信息